PALB2 mutation as a predictive biomarker for immunotherapy in patients with advanced melanoma: Results from (a pooled analysis of) five multicenter, randomized clinical trials. The PPV thresholds can ...
Preferences for research participation among individuals with Lynch syndrome: Findings from the HEROIC Registry. Real-world evidence of treatment patterns and pharmacy costs among patients with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback